Allergan breast implants have been removed from the global market. In Februaryhealth officials began notifying and warning the public that a rare cancer, anaplastic large cell lymphoma or BIA-ALCL, was linked to a certain type of textured breast implant. Now, those potentially harmful implants have finally been recalled.
CNN Allergan issued a worldwide recall of Biocell textured breast implants and tissue expanders that have been linked to a rare cancer. The move came after the US Food and Drug Administration requested the manufacturer voluntarily recall the products. Chat with us in Facebook Messenger.
Skip navigation! Story from Plastic Surgery. A little over two years ago, the Food and Drug Administration claimed that it had identified an association between textured breast implants and anaplastic large cell lymphoma, which is not a breast cancer but a rare type of non-Hodgkin's lymphoma that starts in white blood cells and is commonly referred to as BIA-ALCL.
In a letter to doctors, nurses and other health professionals, the FDA has issued a warning concerning a rare cancer linked to breast implants. The cancer, known as breast implant-associated anaplastic large cell lymphoma, usually forms in scar tissue that forms around implants. However, it should be noted that the disease is not breast cancer. The FDA warning applies to all types of breast implants, both saline and silicone.
This decision will raise many questions for Canadians who have textured breast implants. Patients are advised to have a thorough discussion with their plastic surgeon about the risks and benefits of their implant type should they have any concerns with their implants. We encourage you to speak with your plastic surgeon should you have questions or concerns regarding your implants.
Allergan agreed and is removing these products from the global market. The FDA will continue to evaluate any new information and may, as a result, take action regarding other breast implants, if warranted. Therefore, at the present time, we believe all individuals who are considering a breast implant of any type be informed of the risk of developing BIA-ALCL.
Hazard alert — risk of breast implant-associated anaplastic large cell lymphoma in rare cases. Consumers and health professionals are advised that Allergan has elected to recall all of their un-implanted macro-textured breast implants and tissue expanders due to the risk of breast implant-associated anaplastic large cell lymphoma BIA-ALCL in rare cases. Micro textured and smooth breast implants are not affected by this hazard alert and sponsor initiated recall.
Today, the U. Food and Drug Administration FDA requested that Allerganthe manufacturer of a specific type of textured breast implant, recall specific models of its textured implants from the U. The recall also includes tissue expanders used by patients prior to breast augmentation or reconstruction, including Natrelle Plus Tissue Expander and Natrelle Tissue Expander with Suture Tabs.
Textured breast implants made by Allergan that have been linked to an unusual cancer are being recalled in the United States at the request of the Food and Drug Administrationand will also be recalled globally, the agency announced on Wednesday. The F. Worldwide, cases and 33 deaths from the cancer have been reported, with of the cases clearly attributed to Allergan Biocell implantsthe F. Of the 33 deaths, the agency said its data showed that the type of implant was known in 13 cases, and in 12 of those cases the maker was Allergan.